Article
Ophthalmology
Abduqodir H. Toychiev, Khulan Batsuuri, Miduturu Srinivas
Summary: The study revealed an increase in Cx43 expression and GJ coupling in retinal astrocytes during retinal ischemia/reperfusion injury, leading to exacerbate RGC loss. Deleting astrocytic Cx43 improved neuronal survival in acute ischemia, while pharmacological inhibition of GJ coupling provided neuroprotection in the injury condition.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
(2021)
Article
Pharmacology & Pharmacy
Giovanni Luca Romano, Lucia Gozzo, Oriana Maria Maurel, Serena Di Martino, Valentina Riolo, Vincenzo Micale, Filippo Drago, Claudio Bucolo
Summary: The topical ocular administration of FLX was found to have a neuroprotective effect in a mouse model of acute retinal damage, as it counteracted the damage of retinal ganglion cells and preserved retinal function. FLX treatment also reduced the production of pro-inflammatory molecules elicited by retinal injury. Further studies are needed to support the use of FLX as a neuroprotective agent in retinal degenerative diseases.
Article
Immunology
Yunhong Shi, Yidan Liu, Caiqing Wu, Xiuxing Liu, Wenfei Hu, Zhenlan Yang, Zhidong Li, Yangyang Li, Caibin Deng, Kun Wei, Chenyang Gu, Xuhao Chen, Wenru Su, Yehong Zhuo
Summary: Through single-cell RNA sequencing and molecular docking experiments, it was found that N,N-dimethyl-3 beta-hydroxycholenamide (DMHCA) could suppress inflammatory gene expression, restore retinal structure, and potentially be used as a treatment strategy against retinal ischemia-reperfusion (RIR) injury. The study also identified Ninj1 as a key player in microglia-mediated inflammation and demonstrated that DMHCA exerted its anti-inflammatory effect by downregulating Ninj1 expression.
JOURNAL OF NEUROINFLAMMATION
(2023)
Article
Medicine, Research & Experimental
Mohamed J. Saadh, Roxana Yolanda Castillo-Acobo, Hala Baher, Jayasankar Narayanan, Jessica Paola Palacios Garay, Michelle Naomi Vera Yamaguchi, Jose Luis Arias-Gonzales, Juan Carlos Cotrina-Aliaga, Shaik Vaseem Akram, Natrayan Lakshmaiya, Ali H. Amin, Mohamed Mohany, Salim S. Al-Rejaie, Muhammad Ahsan, Abolfazl Bahrami, Reza Akhavan-Sigari
Summary: This study investigates the potential of sulforaphane (SFN) and Homer1a in regulating cell apoptosis induced by retinal ischemia/reperfusion (I/R) injury. Results show that SFN reverses cell apoptosis and increased intracellular Ca2+ activity, while upregulation of Homer1a decreases cell apoptosis. These findings provide a theoretical basis for clinical treatment.
Article
Chemistry, Multidisciplinary
Zhuhong Zhang, Shengjun Peng, Tengyan Xu, Jia Liu, Laien Zhao, Hui Xu, Wen Zhang, Yuanying Zhu, Zhimou Yang
Summary: In this study, a self-assembling peptide GFFYE was designed and synthesized to transform rhein, a hydrophobic compound, into a sustained-release therapeutic agent. Rhein-based nanofibers were constructed for the treatment of retinal ischemia-reperfusion (RIR) injury, and they showed significant improvement in oxidative stress and inflammation. Moreover, the nanofibers promoted the transition of macrophages from pro-inflammatory to anti-inflammatory type.
Article
Pharmacology & Pharmacy
Federica Conti, Giovanni Luca Romano, Chiara Maria Eandi, Mario Damiano Toro, Robert Rejdak, Giulia Di Benedetto, Francesca Lazzara, Renato Bernardini, Filippo Drago, Giuseppina Cantarella, Claudio Bucolo
Summary: The study demonstrated that brimonidine effectively protected the function of RGCs in mouse eyes and regulated the inflammatory biomarkers induced by retinal ischemia reperfusion injury.
FRONTIERS IN PHARMACOLOGY
(2021)
Article
Biochemistry & Molecular Biology
Galina Dvoriantchikova, Emily Adis, Karin Lypka, Dmitry Ivanov
Summary: Retinal ischemia-reperfusion (IR) leads to retinal ganglion cell (RGC) death, and inhibiting the corresponding signaling cascades can prevent programmed cell death (PCD). In this study, a mouse model of retinal IR was used to investigate PCD pathways in ischemic RGCs. The results show that genetic ablation of death receptors can protect RGCs from IR-induced damage.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Biochemistry & Molecular Biology
Jiarui Feng, Lilong Zhang, Enfu Xue, Zhendong Qiu, Ning Hu, Kunpeng Wang, Yingru Su, Weixing Wang
Summary: In this study, the role of the celiac ganglion (CG) in hepatic ischemia-reperfusion injury (HIRI) was investigated. The results showed that silencing Bmal1 expression in the CG can reduce liver fat reserve, hepatocyte apoptosis, and liver fibrosis, and increase liver glycogen accumulation. Furthermore, the downregulation of Bmal1 can suppress the levels of hepatic neurotransmitters norepinephrine and neuropeptide Y, as well as sympathetic nerve activity in HIRI. Additionally, decreased Bmal1 expression in the CG can reduce inflammation, oxidative stress, and increase glutathione levels in the liver. These findings suggest that reducing Bmal1 expression in the CG can improve hepatocyte injury in HIRI.
Article
Neurosciences
Siyu Zeng, Lei Du, Guojing Lu, Yiqiao Xing
Summary: In this study, it was found that cellular repressor of E1A-stimulated genes (CREG) protected retinal ganglion cells (RGCs) from ischemia-reperfusion injury (RIRI) by activating the Akt signaling pathway and regulating apoptotic proteins. CREG also improved retinal function and visual acuity.
MOLECULAR NEUROBIOLOGY
(2023)
Article
Cell Biology
Lianghe Wen, Minnan Wang, Peiyao Luo, Xianglin Meng, Mingyan Zhao
Summary: Melatonin has been shown to have cardioprotective effects against cardiac damage induced by myocardial infarction. It inhibits NLRP3 inflammasome-induced pyroptosis through modulation of the TLR4/NF-kappa B signaling pathway. This study provides strong evidence for the potential utility of melatonin in the treatment of myocardial infarction.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
(2021)
Article
Ophthalmology
Ru Zhao, Tao He, Yiqiao Xing, Jinyuan Luo
Summary: This study finds that COG1410 regulates the state of microglia and protects retinal ganglion cells in retinal ischemia-reperfusion injury, showing promising potential for the treatment of eye diseases.
EXPERIMENTAL EYE RESEARCH
(2023)
Article
Medicine, Research & Experimental
Wenya Bai, Siying Huo, Guilin Zhou, Junjie Li, Yuan Yang, Jianlin Shao
Summary: This study investigated the potential of Biliverdin to alleviate cerebral ischemia reperfusion injury (CIRI) by inhibiting pyroptosis. Biliverdin was found to significantly alleviate CIRI both in vivo and in vitro by activating the Nrf2/A20/eEF1A2 axis, which in turn inhibited the NF-KB pathway. The findings of this study provide insights into novel therapeutic targets for the treatment of CIRI.
BIOMEDICINE & PHARMACOTHERAPY
(2023)
Article
Biotechnology & Applied Microbiology
Hong-yan Du, Rong Wang, Jian-liang Li, Huang Luo, Xiao-yan Xie, Ran Yan, Yue-ling Jian, Jin-ying Cai
Summary: The study demonstrated that low-concentration ligustrazine has a significant protective effect on RGC-5 cells with retinal I/R injury by activating the PI3K/Akt/mTOR pathway. Low-concentration ligustrazine can enhance cell viability, suppress cell autophagy and apoptosis, thereby protecting against retinal I/R injury.
Article
Immunology
Lijuan Ma, Xueqi Liu, Mengya Zhang, Lang Zhou, Ling Jiang, Li Gao, Xian Wang, Yuebo Huang, Hanxu Zeng, Yonggui Wu
Summary: This article discusses the complicated pathophysiological mechanism of acute kidney injury (AKI) and the lack of effective drugs. It also introduces a newly discovered cell death mode called ferroptosis, which is involved in the progression of AKI. Paeoniflorin (PF), a traditional Chinese medicine, has protective effects on kidney diseases including AKI, but the mechanism of PF in attenuating AKI is unclear.
INTERNATIONAL IMMUNOPHARMACOLOGY
(2023)
Article
Nanoscience & Nanotechnology
Yazhong Wei, Minfang Zhu, Saiqi Li, Ting Hong, Xiaoyu Guo, Yongyong Li, Yiqiong Liu, Xumin Hou, Bin He
Summary: PDA@M, a nanoplatform, can target infarcted myocardium to provide antioxidative and antipyroptosis functions for myocardial protection against MI/RI-induced oxidative stress. The results demonstrate that PDA@M significantly reduces infarct size and improves cardiac function post-MI/RI.
ACS APPLIED MATERIALS & INTERFACES
(2021)
Article
Ophthalmology
Min Chen, Naiji Yu, Chunlian Huang, Qi Zhang, Xin Liu, Kaijun Wang
Summary: This study compared the 1-year outcomes of CO2 laser-assisted sclerectomy surgery (CLASS) alone or combined with phacoemulsification (CLASS + Phaco) in eyes with primary open-angle glaucoma (POAG). The results showed that CLASS alone achieved a greater reduction in intraocular pressure (IOP) and had a higher success rate, while combination surgery resulted in better improvement in best corrected visual acuity (BCVA) and a lower incidence of peripheral anterior synechiae (PAS) formation.
OPHTHALMOLOGY AND THERAPY
(2022)